CPRX• Equity Asset
CPRX Equity (CPRX)
$23.40
+1.90% (24H)
Indicative Static SnapshotExecution State:🟢 IN_BUY_ZONE (Optimal Accumulation)
Composite Score:89/100
🛡️ Strategic Moat & Fundamental Intelligence
Orphan disease commercialization leader (Firdapse) with long-duration exclusivity and 88%+ gross margins.
🔥 Upcoming Catalyst Milestone:
Agamree Duchenne muscular dystrophy international commercial rollout.
🏛️ Regulatory & Political Context:
FDA Rare Pediatric Disease Priority Review Voucher reauthorization legislation.
Launch Interactive TradingView Chart & Position Sizer
Stream live order flow, VWAP overlays, options sweeps, and customized capital risk sizing for CPRX.
🎯 Mark Minervini VCP Execution Ladder
View Execution Math Guide →Stop Loss (Exit)$22.46Invalidation Floor
Optimal Accumulation$23.02 - $23.40Institutional Pocket
Target 1 (Scale 50%)$25.27+2.5x ATR14 Expansion
Target 2 (Runner Exit)$26.77+4.5x ATR14 Extended
📊 5-Factor Fundamental DNA & Quality Scorecard
Piotroski Guide →Growth Score
88/ 100
Quality Score
95/ 100
Valuation Score
85/ 100
Momentum Score
86/ 100
Tail Risk Safety
90/ 100
Piotroski F-Score
9/ 9 (Pristine)
📊
Historical Win-Rate & Strategy Edge (CPRX)
68.4% WIN RATEReal backtested statistics over 1,420 historical trades so you know the exact odds before taking this trade.
Profit Multiplier2.45x
Win Percentage68.4%
Average Gain on Winner+18.4%
Typical Days to Profit12 Days
Max Pattern Drop-5.2%
💡 Golden Rule:Requires 3-stage volatility contraction with declining volume on pullbacks before 50-day pivot breakout.